Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	subject type
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	28133	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	34761	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	37214	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	38488	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	42865	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	47908	Peak area	Severe disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	52667	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	57362	Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-	71112	Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-		Peak area	Healthy control
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-		Peak area	Mild disease
Reversed phase NEGATIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M-H)-		Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	92408	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	298375	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	302721	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	308104	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	312505	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	330438	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	338273	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	367357	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	378752	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	389461	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	390912	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	394711	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	398845	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	401888	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	427576	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	428787	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+	483259	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+H)+		Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	3547	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	6818	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	6966	Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	7739	Peak area	Severe disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	8021	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	8097	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+	8150	Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+		Peak area	Healthy control
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+		Peak area	Mild disease
Reversed phase POSITIVE ION MODE	HOMOSERINE (CAS# 672-15-1); (M+NA)+		Peak area	Severe disease